Bookmark

Add to MyYahoo RSS

CGI Pharmaceuticals News

News on CGI Pharmaceuticals (Ticker: GILD) continually updated from thousands of sources around the net.

Thursday Apr 17 | SFGate

Why Everyone Wants To Work In Biotech

Companies like Celgene, Biogen Idec, and Gilead Sciences all took top spots on our list of the Best Employers in America .

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Celgene, Business News

Tue Apr 15, 2014

Business Wire

Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014

At 4:15 p.m. Eastern Time, Gilead's management will host a conference call to discuss the company's financial results for the first quarter 2014 and provide a general business update.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups

Mon Apr 14, 2014

Sympatico Finance

Biotech stocks stronger than Nasdaq's latest weakness [04-14-14 12:30 PM]

Activist investor Daniel Loeb, who is fighting to win control of three board seats at Sotheby's , on Monday raised the temperature by saying the current board has failed and that its attacks on him are "false" and "misleading."

Comment?

Related Topix: Financial Markets, Retail, Auctions, Sothebys Holdings, Startups, Gilead Sciences

GantDaily.com

Biotech firms, investors biding time for breakthrough drugs

New York, NY, United States - Many biotech firms are now biding their time, waiting for their research projects to result in a breakthrough drug that will not only cure a once untreatable disease but could also make the company more profitable.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Amgen, Healthcare Industry, Gilead Sciences, Startups

Aidsmap

Sofosbuvir + simeprevir dual therapy shows high cure rates for...

A 12-week oral regimen of sofosbuvir plus simeprevir without pegylated interferon or ribavirin led to sustained virological response in 93% of genotype 1 hepatitis C patients with either absent to moderate liver fibrosis or with advanced fibrosis or cirrhosis, according to data from the COSMOS trial presented last week at the 49th EASL ... (more)

Comment?

Sat Apr 12, 2014

SFGate

Cost of Gilead's hepatitis C pill, Sovaldi, spurs revolt

Orlando Chavez, who works at the Berkeley Free Clinic, was cured of hepatitis C in 2005 after painful treatment and says he would have jumped on Gilead's new drug, Sovaldi, at any price.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Hepatitis, Health, Berkeley, CA, Startups, Science / Technology

SiliconValley.com

Gilead

The health and biomedical industries in Silicon Valley saw a 15.5 percent increase in profits in 2013 -- representing $4.4 billion -- but, perhaps more importantly, venture capital also began flowing after nearly five years of lean investments.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Foster City, CA, Startups

Fri Apr 11, 2014

Forbes.com

Friday's ETF Movers: BBH, XME

In trading on Friday, the Biotech ETF is outperforming other ETFs, up about 0.4% on the day.

Comment?

Related Topix: Biotech, Startups, Medicine, Gilead Sciences, Healthcare Industry, Incyte, Financial Markets

TheStreet.com

Drying Stimulus Tap Is Sore Spot for Tech Stocks

NEW YORK -- The drying stimulus tap rather than stretched valuations has been the trigger for recent selling in tech and biotech shares, some managers argue, claiming this makes another tech sector crash unlikely.

Comment?

Related Topix: Financial Markets, TheStreetcom, Media, TheStreet, Computers, Startups, Gilead Sciences

Barron's

Gold Closes Near Three-Week High As Stocks Tumble; Oil, Biotech & Bitcoin Fall

Gold started higher this morning, boosted by the Federal Reserve's dovish remarks Wednesday, and continued to gain throughout the day as stocks slid and the Nasdaq neared its worst loss in nearly two years.

Comment?

Related Topix: Financial Markets, Biotech, Science / Technology, Economics News, Bitcoin, Startups, Medicine, Gilead Sciences, Healthcare Industry

The Miami Herald

How the Dow Jones industrial average did Thursday

Biotech and Internet stocks tumbled again Thursday, and the broader market followed.

Comment?

Related Topix: Startups, Gilead Sciences, Social Software

Information Technology

Gilead's Sovaldi Demonstrates Efficacy and Safety Among Chronic...

Gilead Sciences, Inc. today announced data from two Phase 2 studies and a compassionate access study in which a regimen containing once-daily Sovaldi 400 mg was administered for the treatment of chronic hepatitis C virus infection in patients with advanced liver disease.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Hepatitis, Health

Thu Apr 10, 2014

The Campbell Reporter

Biz Break: Silicon Valley tech stocks slaughtered ahead of earnings reports

Traders Kevin Lodewick, left, and Timothy Nick work on the floor of the New York Stock Exchange Thursday, April 10, 2014.

Comment?

Related Topix: Financial Markets, Biotech, Science / Technology, Social Software, Redwood City, CA, Startups, Gilead Sciences

Barron's

Biotech: Like Lambs to the Slaughter

The iShares Nasdaq Biotech ETF fell 5.6% to $221.89 today, while the SPDR S&P Biotechnology ETF dropped 6.5% to $129.79.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Gilead Sciences, Healthcare Industry, Startups, Amgen, Celgene

Star-Telegram.com

Stocks drop; Biotech takes another plunge

Stocks are sharply lower in afternoon trading as investors dump biotechnology shares and other industries that soared over the past year.

Comment?

Related Topix: Science / Technology, Financial Markets, Biotech, Startups, Gilead Sciences

Seattle Post-Intelligencer

Stocks take another tumble; eBay heads lower

U.S. stock indexes were drifting lower Thursday as investors picked over a mixed batch of corporate earnings reports.

Comment?

Related Topix: Financial Markets, Startups, Gilead Sciences, Biotech, Science / Technology

The Motley Fool

Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Inc.

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Bristol-Myers Squibb therapy for genotype 1b hepatitis C at the 49th Annual Meeting of the European Association for the Study of the Liver in London today.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Gilead Sciences, Startups, Hepatitis, Health, Healthcare Law, Law

Tue Apr 08, 2014

National Public Radio

Investors Shed Tech, Biotech Stocks

Technology and biotechnology companies, high-flying stocks over the last two years, have been beaten down the last three weeks.

Comment?

Related Topix: Financial Markets, Biotech, Science / Technology, Startups, Gilead Sciences

Minyanville

Biotech Stocks to Watch as Sector Sells Off

The sharp drop in the iShares Nasdaq Biotechnology ETF in the last month erased all the gains made for the year.

Comment?

Related Topix: Biotech, Science / Technology, Financial Markets, Medicine, Gilead Sciences, Healthcare Industry, Amgen, Startups

Mon Apr 07, 2014

Benzinga

TD Ameritrade Says IMX for Mar. Up to 5.87

The S&P 500 climbed to a new record early in the month, but then took a few steps down to eventually close the month relatively flat compared to February.

Comment?

Related Topix: Financial Markets, Mutual Funds, Personal Finance, Biotech, Startups, Medicine, Gilead Sciences, Healthcare Industry, Plug Power, Electronics

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••